140 related articles for article (PubMed ID: 9828865)
1. Intralesional cisplatin for the treatment of cutaneous B-cell lymphoma.
Kempf W; Dummer R; Schmid MH; Fritz T; Wüthrich B; Burg G
Arch Dermatol; 1998 Nov; 134(11):1343-5. PubMed ID: 9828865
[No Abstract] [Full Text] [Related]
2. [Granulomatous slack skin: partial remission following intralesional administration of interferon-alpha and PUVA].
Schmook T; Hofbauer G; Kempf W; Burg G; Dummer R
Hautarzt; 2001 Oct; 52(10 Pt 2):985-8. PubMed ID: 11715400
[TBL] [Abstract][Full Text] [Related]
3. Treatment of cutaneous T-cell lymphoma with alitretinoin gel.
Bassiri-Tehrani S; BA BA; Cohen DE
Int J Dermatol; 2002 Feb; 41(2):104-6. PubMed ID: 11982647
[No Abstract] [Full Text] [Related]
4. [Clinicopathologic analysis of 7 cases of primary cutaneous NK/T cell lymphoma, nasal type].
Zhou DM; Chen G; Zheng XW; Li C; He YZ
Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):772-3. PubMed ID: 22336163
[No Abstract] [Full Text] [Related]
5. Topical imiquimod therapy for cutaneous T-cell lymphoma.
Do JH; McLaughlin SS; Gaspari AA
Skinmed; 2003; 2(5):316-8. PubMed ID: 14673267
[No Abstract] [Full Text] [Related]
6. Childhood cutaneous natural killer/T lymphoma successfully treated with only one course of chemotherapy and incomplete tumor resection.
Miyazaki M; Lin YW; Okada M; Hamahata K; Kubota M
Haematologica; 2001 Aug; 86(8):883-4. PubMed ID: 11524256
[No Abstract] [Full Text] [Related]
7. Cutaneous intravascular NK/T-cell lymphoma.
Wang J; Yang X; Song Z; You Y
Australas J Dermatol; 2020 Feb; 61(1):61-63. PubMed ID: 31372987
[No Abstract] [Full Text] [Related]
8. The Potential for Teledermatology in Managing and Diagnosing Patients With Cutaneous Lymphomas.
Beer J; Hadeler E; Nouri K
J Drugs Dermatol; 2020 Nov; 19(11):1125. PubMed ID: 33196742
[No Abstract] [Full Text] [Related]
9. Long-term bexarotene monotherapy in large cell CD30+ pleomorphic T-cell lymphoma.
Aldaoud A
Dermatol Clin; 2008 Jan; 26 Suppl 1():15-7. PubMed ID: 18405181
[No Abstract] [Full Text] [Related]
10. Antipruritic vs. Antitumour Action of Aprepitant: A Question of Dose.
Muñoz M; Parrilla J; Rosso M; Coveñas R
Acta Derm Venereol; 2019 May; 99(6):620-621. PubMed ID: 30734049
[No Abstract] [Full Text] [Related]
11. Bexarotene monotherapy for epidermotropic CD8+ CTCL.
Kamstrup M; Gniadecki R
Dermatol Clin; 2008 Jan; 26 Suppl 1():45-7. PubMed ID: 18405187
[No Abstract] [Full Text] [Related]
12. [Low-grade cutaneous B-cell lymphoma: Failure of intralesional rituximab (Mabthera)].
Abasq C; Duval-Modeste AB; Courville P; Joly P
Ann Dermatol Venereol; 2008; 135(6-7):509-11. PubMed ID: 18598807
[No Abstract] [Full Text] [Related]
13. Topical targretin and intralesional interferon alfa for cutaneous lymphoma of the scalp.
Trent JT; Romanelli P; Kerdel FA
Arch Dermatol; 2002 Nov; 138(11):1421-3. PubMed ID: 12437444
[No Abstract] [Full Text] [Related]
14. Pegylated liposomal doxorubicin in the treatment of cutaneous T-cell lymphoma.
Prince HM; Seymour JF; Ryan G; McCormack C
J Am Acad Dermatol; 2001 Jan; 44(1):149-50. PubMed ID: 11148501
[No Abstract] [Full Text] [Related]
15. Successful treatment of primary cutaneous follicle centre lymphoma with topical 5% imiquimod.
Stavrakoglou A; Brown VL; Coutts I
Br J Dermatol; 2007 Sep; 157(3):620-2. PubMed ID: 17553050
[No Abstract] [Full Text] [Related]
16. [Cutaneous cytotoxic T-cell lymphoma].
Weinstabl A; Megahed M; Rütten A; Rübben A
Hautarzt; 2011 May; 62(5):329-32. PubMed ID: 21445701
[TBL] [Abstract][Full Text] [Related]
17. Treatment of cutaneous T-cell lymphoma by retinoids and calcitriol.
Bagot M
Lancet; 1995 Aug; 346(8971):376-7. PubMed ID: 7623547
[No Abstract] [Full Text] [Related]
18. Targeting Tumor-Infiltrating B Cells in Cutaneous T-Cell Lymphoma.
Theurich S; Schlaak M; Steguweit H; Heukamp LC; Wennhold K; Kurschat P; Rabenhorst A; Hartmann K; Schlösser H; Shimabukuro-Vornhagen A; Holtick U; Hallek M; Stadler R; von Bergwelt-Baildon M
J Clin Oncol; 2016 Apr; 34(12):e110-6. PubMed ID: 25348001
[No Abstract] [Full Text] [Related]
19. Regression of multifocal, skin-restricted, CD30-positive large T-cell lymphoma with interferon alfa and bexarotene therapy.
French LE; Shapiro M; Junkins-Hopkins JM; Vittorio CC; Rook AH
J Am Acad Dermatol; 2001 Dec; 45(6):914-8. PubMed ID: 11712039
[TBL] [Abstract][Full Text] [Related]
20. Intralesional Rituximab Treatment for Primary Cutaneous B-cell Lymphoma: Nine Finnish Cases.
Väkevä L; Ranki A; Mälkönen T
Acta Derm Venereol; 2016 Mar; 96(3):396-7. PubMed ID: 26525093
[No Abstract] [Full Text] [Related]
[Next] [New Search]
